| Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers (NCT05192512) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2022-01-24 |
| G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT05222009) | Sun Yat-sen University | 2022-01-24 |
| A Study of BTX-1188 in Subjects With Advanced Malignancies (NCT05144334) | Biotheryx, Inc. | 2022-01-24 |
| Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin (NCT05306379) | Aurinia Pharmaceuticals Inc. | 2022-01-24 |
| Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike Protein (NCT05132907) | HDT Bio | 2022-01-24 |
| An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D (NCT05210530) | CRISPR Therapeutics AG | 2022-01-24 |
| Nebulizer Delivery of Intranasal Scopolamine (NCT04999449) | Dartmouth-Hitchcock Medical Center | 2022-01-24 |
| A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers (NCT05213728) | Vaxart | 2022-01-24 |
| hCT-MSC Infusion in Adults With Autism Spectrum Disorder (NCT04484077) | Joanne Kurtzberg, MD | 2022-01-24 |
| A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL) (NCT05169489) | Regeneron Pharmaceuticals | 2022-01-24 |
| Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART (NCT05144386) | Excision BioTherapeutics | 2022-01-24 |
| Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia (NCT05245539) | Cerevel Therapeutics, LLC | 2022-01-24 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics, With Target Occupancy Study of BIIB113 in Healthy Participants (NCT05195008) | Biogen | 2022-01-24 |
| A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630 (NCT05055050) | M.D. Anderson Cancer Center | 2022-01-24 |
| Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL (NCT05153330) | Biomea Fusion Inc. | 2022-01-24 |
| A First-in-Human Study With XAB05 in Healthy Subjects (NCT05307406) | Xenothera SAS | 2022-01-24 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism (NCT05003960) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-01-23 |
| Local Anesthesia With Lidocaine or Articaine for Molars Affected by MIH (NCT05200884) | Latakia University | 2022-01-22 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty (NCT05018767) | The Foundation for Orthopaedics and Regenerative Medicine | 2022-01-22 |
| A Study of AK112 in Advanced Malignant Tumors (NCT05214482) | Akeso | 2022-01-22 |
| A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors (NCT05173142) | Hutchison Medipharma Limited | 2022-01-22 |
| A Study to Learn How [14C]ASP0367 is Processed by the Body in Healthy Men (NCT05217901) | Astellas Pharma Global Development, Inc. | 2022-01-21 |
| A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors (NCT05143970) | Institut Paoli-Calmettes | 2022-01-21 |
| Isolation of Cells From Biopsy Tissue to Aid in Kidney Repair (NCT04896567) | Brigham and Women's Hospital | 2022-01-21 |
| Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated with HD (NCT04301726) | Fundacion Huntington Puerto Rico | 2022-01-21 |
| Tepotinib Drug-Drug Interaction Study With Itraconazole in Healthy Participants (NCT05203822) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2022-01-21 |
| Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients (NCT05234190) | Quell Therapeutics Limited | 2022-01-21 |
| Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN (NCT05309668) | AstraZeneca | 2022-01-21 |
| A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB086550 (NCT05101369) | Incyte Corporation | 2022-01-21 |
| A Study to Assess the Pharmacokinetics (Uptake of Drugs by the Body), Safety and Tolerability of AZD4831 in Participants With Severe Renal Impairment and Healthy Volunteers (NCT04949438) | AstraZeneca | 2022-01-21 |
| Phase I Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine (NCT05526183) | Ankara City Hospital Bilkent | 2022-01-21 |
| A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection (NCT05170243) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-01-21 |
| The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Conditions (NCT05218616) | JLLC NatiVita | 2022-01-21 |
| Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients (NCT05525650) | RAPHAS | 2022-01-20 |
| A Dose Finding Study of CC-96673 in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT04860466) | Celgene | 2022-01-20 |
| Empagliflozin in Treatment of Peripheral Diabetic Neuropathy (NCT05977465) | Tanta University | 2022-01-20 |
| First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer (NCT05159440) | TORL Biotherapeutics, LLC | 2022-01-20 |
| BAT7104 Injection in Patients With Advanced Malignant Tumors. (NCT05767060) | Bio-Thera Solutions | 2022-01-20 |
| Evaluation of Different Methods for the Diagnosis of Primary Caries Lesions (NCT04900246) | University of Nove de Julho | 2022-01-20 |
| Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19 (NCT05184218) | IGM Biosciences, Inc. | 2022-01-20 |
| Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors (NCT04987112) | CanWell Pharma Inc. | 2022-01-20 |
| Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors (KRYSTAL-16) (NCT05178888) | Mirati Therapeutics Inc. | 2022-01-20 |
| Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients (NCT05499156) | Tehran University of Medical Sciences | 2022-01-20 |
| A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes (NCT05168202) | Bristol-Myers Squibb | 2022-01-19 |
| TT-702 in Patients With Advanced Solid Tumours. (NCT05272709) | Cancer Research UK | 2022-01-19 |
| A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide (NCT05232708) | Novo Nordisk A/S | 2022-01-19 |
| Evaluation of the Relative Bioavailability of Bosutinib Capsules Under Fed Condition and Estimation of Food Effect on Orally Administered Bosutinib Capsule (NCT05032690) | Pfizer | 2022-01-19 |
| FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer (NCT05011188) | Rahul Aggarwal | 2022-01-19 |
| DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy Volunteers (NCT05368857) | Clinuvel (UK) Ltd. | 2022-01-19 |
| A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers (NCT05223101) | HK inno.N Corporation | 2022-01-19 |
| A Study of ZL-1211 in Patients With Advanced Solid Tumor (NCT05065710) | Zai Biopharmaceutical (Suzhou) Co., Ltd. | 2022-01-19 |
| Safety and Pharmacokinetics (PK) Study of Natrunix in Healthy Volunteers (NCT05099510) | XBiotech, Inc. | 2022-01-19 |
| A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus (NCT04967170) | Jennifer R. Arthurs | 2022-01-19 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BPI-21668 (NCT05341570) | Betta Pharmaceuticals Co., Ltd. | 2022-01-19 |
| Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI) (NCT05219695) | Columbia University | 2022-01-19 |
| Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930 (NCT05207761) | Chong Kun Dang Pharmaceutical | 2022-01-19 |
| A Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HH-101 in Patients With Advanced Solid Tumors (NCT07554196) | Huahui Health | 2022-01-19 |
| Tomographic Evaluation of Pulpotomy in Young Permanent Teeth Using Human-treated Dentin Matrix (NCT06116695) | Tanta University | 2022-01-18 |
| Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer (NCT04780568) | Ohio State University Comprehensive Cancer Center | 2022-01-18 |
| Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease (NCT05094050) | AbbVie | 2022-01-18 |
| Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors (NCT04683939) | BioNTech SE | 2022-01-18 |
| Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma (NCT06141109) | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | 2022-01-18 |
| Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 (NCT05313022) | Shanghai Zerun Biotechnology Co.,Ltd | 2022-01-18 |
| Treatment of Advanced and Metastatic Solid Tumors With MIL97 (NCT04965077) | Beijing Mabworks Biotech Co., Ltd. | 2022-01-18 |
| Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT (NCT05277454) | Hutchison Medipharma Limited | 2022-01-18 |
| AN0025 and Chemoradiotherapy Combination in Esophageal Cancer (NCT05191667) | Adlai Nortye Biopharma Co., Ltd. | 2022-01-18 |
| Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD) (NCT05338099) | ENCell | 2022-01-18 |
| Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer (NCT05232175) | Alteogen, Inc. | 2022-01-18 |
| A Study of Oncolytic Virus Injection (RT-01) in Patients With Extensive-Stage Small Cell Lung Cancer (NCT05205421) | The First Affiliated Hospital of Bengbu Medical University | 2022-01-18 |
| Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) (NCT04743505) | Washington University School of Medicine | 2022-01-18 |
| Aerobic Exercise After Traumatic Brain Injury (NCT05786729) | Centre for Neuro Skills | 2022-01-18 |
| XTX202 in Patients With Advanced Solid Tumors (NCT05052268) | Xilio Development, Inc. | 2022-01-18 |
| Evaluation of Apexogenesis With Human Treated Dentin Matrix in Young Permanent Molars (NCT05830695) | nora mostafa mohammed abo shanady | 2022-01-18 |
| Binding and Effects of Lu AG06466 in the Brain of Healthy Men (NCT05219838) | H. Lundbeck A/S | 2022-01-18 |
| LAG3 PET Imaging in Advanced Solid Tumors (NCT04706715) | University Medical Center Groningen | 2022-01-18 |
| A Study of Single Ascending Doses of IW-3300 in Healthy Volunteers (NCT05188261) | Ironwood Pharmaceuticals, Inc. | 2022-01-18 |
| To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers (NCT05463497) | JW Pharmaceutical | 2022-01-17 |
| Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers (NCT05105243) | Cerevance | 2022-01-17 |
| Stress Interventions in STEM and Non-STEM (NCT05376306) | Rutgers, The State University of New Jersey | 2022-01-17 |
| Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma (NCT04895410) | AbbVie | 2022-01-17 |
| Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer (NCT05369000) | Lava Therapeutics | 2022-01-17 |
| A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease (NCT05193201) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2022-01-16 |
| Food Effect Study of IDX-1197 in Healthy Subjects (NCT05202912) | Idience Co., Ltd. | 2022-01-16 |
| A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19 (NCT05156645) | Sinocelltech Ltd. | 2022-01-15 |
| Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis (NCT05215990) | Mahidol University | 2022-01-15 |
| A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer (NCT05145140) | Affiliated Hospital of Nantong University | 2022-01-15 |
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) (NCT05266196) | Salarius Pharmaceuticals, LLC | 2022-01-15 |
| A Study of 14C JNJ-67953964 in Healthy Adult Male Participants (NCT05197062) | Janssen Research & Development, LLC | 2022-01-14 |
| Methylphenidate for Ptsd and Stroke Veterans (NCT04885257) | VA Office of Research and Development | 2022-01-14 |
| Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors (NCT05154630) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-01-14 |
| Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents (NCT05061030) | Uppsala University Hospital | 2022-01-14 |
| TMS and Exercise for Post-stroke Pain (NCT04672044) | VA Office of Research and Development | 2022-01-14 |
| A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL (NCT04984356) | Allotera Therapeutics | 2022-01-14 |
| A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors (NCT05074472) | ZielBio, Inc. | 2022-01-14 |
| ApTOLL for the Treatment of COVID-19 (NCT05293236) | Macarena Hernández Jiménez | 2022-01-14 |
| Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma (NCT05154994) | University of Utah | 2022-01-14 |
| Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects (NCT05189288) | Chong Kun Dang Pharmaceutical | 2022-01-14 |
| A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food (NCT05155306) | Boehringer Ingelheim | 2022-01-14 |
| Trial of an Inactivated Yellow Fever Virus Vaccine (NCT05172544) | Najit Technologies, Inc. | 2022-01-13 |
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC (NCT05153408) | Blueprint Medicines Corporation | 2022-01-13 |